【摘 要】
:
BACKGROUND^177Lu peptide receptor radionuclide therapy(PRRT)is a recently approved therapy in Spain that has been demonstrated to be a well-tolerated therapy fo
【机 构】
:
DepartmentofNuclearMedicine,DepartmentofOncology,DepartmentofEndocrinology,DepartmentofPathology,Dep